Identification of Somatic Mitochondrial DNA Mutations, Heteroplasmy, and Increased Levels of Catenanes in Tumor Specimens Obtained from Three Endometrial Cancer Patients.
Identification of Somatic Mitochondrial DNA Mutations, Heteroplasmy, and Increased Levels of Catenanes in Tumor Specimens Obtained from Three Endometrial Cancer Patients.
复制标题
鉴定体细胞线粒体DNA突变,异质性,和增加水平的肿瘤标本从三个子宫内膜癌患者。
DOI:
10.3390/life12040562
复制
发表时间:
2022-04-09
期刊:
影响因子:
3.2
通讯作者:
Young, Carolyn K. J.
中科院分区:
文献类型:
--
作者:
Young, Matthew J.;Sachidanandam, Ravi;Hales, Dale B.;Brard, Laurent;Robinson, Kathy;Rahman, Md Mostafijur;Khadka, Pabitra;Groesch, Kathleen;Young, Carolyn K. J.
关键词:
Endometrial carcinoma (EC) is the most common type of gynecologic malignant epithelial tumor, with the death rate from this disease doubling over the past 20 years. Mitochondria provide cancer cells with necessary anabolic building blocks such as amino acids, lipids, and nucleotides, and EC samples have been shown to increase mitochondrial biogenesis. In cancer, mitochondrial DNA (mtDNA) heteroplasmy studies suggest that heteroplasmic variants encode predicted pathogenic proteins. We investigated the mtDNA genotypes within peri-normal and tumor specimens obtained from three individuals diagnosed with EC. DNA extracts from peri-normal and tumor tissues were used for mtDNA-specific next-generation sequencing and analyses of mtDNA content and topoisomers. The three tumors harbor heteroplasmic somatic mutations, and at least one mutation in each carcinoma is predicted to deleteriously alter a mtDNA-encoded protein. Somatic heteroplasmy linked to two mtDNA tRNA genes was found in separate tumors, and two heteroplasmic non-coding variants were identified in a single EC tumor. While two tumors had altered mtDNA content, all three displayed increased mtDNA catenanes. Our findings support that EC cells require wild-type mtDNA, but heteroplasmic mutations may alter mitochondrial metabolism to help promote cancer cell growth and proliferation.
登录
查看更多内容
影响因子:
7.7
作者:
Ju YS;Alexandrov LB;Gerstung M;Martincorena I;Nik-Zainal S;Ramakrishna M;Davies HR;Papaemmanuil E;Gundem G;Shlien A;Bolli N;Behjati S;Tarpey PS;Nangalia J;Massie CE;Butler AP;Teague JW;Vassiliou GS;Green AR;Du MQ;Unnikrishnan A;Pimanda JE;Teh BT;Munshi N;Greaves M;Vyas P;El-Naggar AK;Santarius T;Collins VP;Grundy R;Taylor JA;Hayes DN;Malkin D;ICGC Breast Cancer Group;ICGC Chronic Myeloid Disorders Group;ICGC Prostate Cancer Group;Foster CS;Warren AY;Whitaker HC;Brewer D;Eeles R;Cooper C;Neal D;Visakorpi T;Isaacs WB;Bova GS;Flanagan AM;Futreal PA;Lynch AG;Chinnery PF;McDermott U;Stratton MR;Campbell PJ
通讯作者:
Campbell PJ
影响因子:
56.9
作者:
Ishikawa, Kaori;Takenaga, Keizo;Hayashi, Jun-Ichi
通讯作者:
Hayashi, Jun-Ichi
影响因子:
3.5
作者:
Guerra, Flora;Kurelac, Ivana;Gasparre, Giuseppe
通讯作者:
Gasparre, Giuseppe
影响因子:
1.2
作者:
Hardarson, Hordur Alexander;Heidemann, Lene Nyhoj;dePont Christensen, Rene;Mogensen, Ole;Jochumsen, Kirsten M
通讯作者:
Jochumsen, Kirsten M
影响因子:
20.8
作者:
Gorelick, Alexander N.;Kim, Minsoo;Chatila, Walid K.;La, Konnor;Hakimi, A. Ari;Berger, Michael F.;Taylor, Barry S.;Gammage, Payam A.;Reznik, Ed
通讯作者:
Reznik, Ed